Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06539169 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06539169 · ClinicalTrials.gov record · last posted 2024-11-14

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

StatusRecruiting
PhaseNot specified
SponsorxCures
Started2024-06-10
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 14, 2024 (before its estimated June 10, 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
FLOWER is a completely virtual, nationwide, real-world observational study to collect, annotate, standardize, and report clinical data for rare diseases. Patients participate in the study by electronic consent (eConsent) and sign a medical records release to permit data collection. Medical records are accessed from institutions directly via eFax or paper fax, online from patient electronic medical record (EMR) portals, direct from DNA/RNA sequencing and molecular profiling vendors, and via electronic health information exchanges. Patients and their treating physicians may also optionally provide medical records. Medical records are received in or converted to electronic/digitized formats (CCDA, FHIR, PDF), sorted by medical record type (clinic visit, in-patient hospital, out-patient clinic, infusion and out-patient pharmacies, etc.) and made machine-readable to support data annotation, full text searches, and natural language processing (NLP) algorithms to further facilitate feature identification.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2024-08-01; most recent amendment 2024-11-12. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details
NCT Number NCT06539169
Lead Sponsor xCures
Conditions Alpha-Thalassemia, Beta-Thalassemia, Amyloidosis, Amyotrophic Lateral Sclerosis, Creutzfeld-Jakob Disease, Cystic Fibrosis, Duchenne Muscular Dystrophy, Early-Onset Alzheimer Disease +9 more
Enrollment 1,000 participants
Start Date 2024-06-10
Primary Completion 2026-06-10 (estimated)
Study Completion 2026-06-10 (estimated)
Updated on ClinicalTrials.gov 2024-11-14